Jane Street’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $289K | Sell |
19,500
-126,600
| -87% | -$1.85M | ﹤0.01% | 9316 |
|
|
2025
Q4 | $2.33M | Sell |
146,100
-1,700
| -1% | -$24.1K | ﹤0.01% | 4510 |
|
|
2025
Q3 | $1.63M | Buy |
147,800
+24,900
| +20% | +$272K | ﹤0.01% | 5311 |
|
|
2025
Q2 | $1.04M | Sell |
122,900
-3,700
| -3% | -$29.7K | ﹤0.01% | 5542 |
|
|
2025
Q1 | $1.02M | Sell |
126,600
-99,100
| -44% | -$803K | ﹤0.01% | 5537 |
|
|
2024
Q4 | $2.03M | Buy |
225,700
+66,900
| +42% | +$546K | ﹤0.01% | 4077 |
|
|
2024
Q3 | $1.16M | Buy |
158,800
+600
| +0.4% | +$3.72K | ﹤0.01% | 5590 |
|
|
2024
Q2 | $903K | Sell |
158,200
-17,900
| -10% | -$94.3K | ﹤0.01% | 5955 |
|
|
2024
Q1 | $882K | Buy |
176,100
+134,900
| +327% | +$915K | ﹤0.01% | 5635 |
|
|
2023
Q4 | $370K | Sell |
41,200
-41,000
| -50% | -$338K | ﹤0.01% | 7291 |
|
|
2023
Q3 | $639K | Sell |
82,200
-193,800
| -70% | -$1.9M | ﹤0.01% | 5886 |
|
|
2023
Q2 | $2.67M | Buy |
276,000
+184,900
| +203% | +$1.92M | ﹤0.01% | 3694 |
|
|
2023
Q1 | $998K | Buy |
91,100
+72,800
| +398% | +$641K | ﹤0.01% | 4997 |
|
|
2022
Q4 | $79.1K | Sell |
18,300
-215,500
| -92% | -$1.25M | ﹤0.01% | 8217 |
|
|
2022
Q3 | $1.76M | Buy |
233,800
+50,200
| +27% | +$435K | ﹤0.01% | 4412 |
|
|
2022
Q2 | $1.84M | Sell |
183,600
-212,700
| -54% | -$2.38M | ﹤0.01% | 4322 |
|
|
2022
Q1 | $4.91M | Sell |
396,300
-103,800
| -21% | -$1.6M | ﹤0.01% | 3057 |
|
|
2021
Q4 | $11.4M | Sell |
500,100
-75,800
| -13% | -$1.8M | ﹤0.01% | 1722 |
|
|
2021
Q3 | $12.7M | Buy |
575,900
+197,700
| +52% | +$3.14M | ﹤0.01% | 1502 |
|
|
2021
Q2 | $4.9M | Buy |
378,200
+350,500
| +1,265% | +$4.46M | ﹤0.01% | 2669 |
|
|
2021
Q1 | $360K | Sell |
27,700
-174,000
| -86% | -$2.52M | ﹤0.01% | 7396 |
|
|
2020
Q4 | $2.79M | Buy |
201,700
+158,400
| +366% | +$2.31M | ﹤0.01% | 2918 |
|
|
2020
Q3 | $638K | Sell |
43,300
-15,400
| -26% | -$223K | ﹤0.01% | 4781 |
|
|
2020
Q2 | $954K | Buy |
58,700
+47,100
| +406% | +$754K | ﹤0.01% | 4130 |
|
|
2020
Q1 | $168K | Sell |
11,600
-23,800
| -67% | -$420K | ﹤0.01% | 4725 |
|
|
2019
Q4 | $717K | Buy |
+35,400
| New | +$326K | ﹤0.01% | 3227 |
|
Other funds holding AUPH
TCM
NMC
